Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Entasis Therapeutics (ETTX) Short Interest Ratio & Short Volume

Entasis Therapeutics logo

Entasis Therapeutics Short Interest Data

Entasis Therapeutics (ETTX) has a short interest of 72,400 shares, representing 0.50% of the float (the number of shares available for trading by the public). This marks a -3.34% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 239,104 shares to cover all short positions.

Current Short Interest
72,400 shares
Previous Short Interest
74,900 shares
Change Vs. Previous Month
-3.34%
Dollar Volume Sold Short
$157.83 thousand
Short Interest Ratio
0.3 Days to Cover
Last Record Date
June 15, 2022
Outstanding Shares
47,852,000 shares
Float Size
14,440,000 shares
Short Percent of Float
0.50%
Today's Trading Volume
800 shares
Average Trading Volume
239,104 shares
Today's Volume Vs. Average
0%
Short Selling Entasis Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Entasis Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ETTX Short Interest Over Time

ETTX Days to Cover Over Time

ETTX Percentage of Float Shorted Over Time

Entasis Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/15/202272,400 shares $157.83 thousand -3.3%0.5%0.3 $2.18
5/31/202274,900 shares $163.28 thousand -28.7%0.5%0.4 $2.18
5/15/2022105,100 shares $189.18 thousand -35.4%0.7%0.6 $1.80
4/30/2022162,700 shares $305.88 thousand -21.1%1.1%2.1 $1.88
4/15/2022206,100 shares $389.53 thousand +8.3%1.4%0.8 $1.89
3/31/2022190,400 shares $356.05 thousand -4.3%N/A0.7 $1.87
3/15/2022199,000 shares $370.14 thousand -20.5%1.4%0.8 $1.86
2/28/2022250,300 shares $425.51 thousand -16.0%1.8%0.9 $1.70
2/15/2022298,000 shares $536.40 thousand -19.1%2.1%1.1 $1.80
1/31/2022368,300 shares $541.40 thousand -3.1%2.6%1.3 $1.47
1/15/2022380,000 shares $729.60 thousand +3.0%N/A0 $1.92
12/31/2021368,900 shares $807.89 thousand -19.2%2.4%1.2 $2.19
12/15/2021456,800 shares $991.26 thousand +9.2%3.0%1.5 $2.17
11/30/2021418,500 shares $1.08 million -8.0%2.8%1.1 $2.58
11/15/2021454,900 shares $1.27 million +42.1%3.0%1.2 $2.80
10/29/2021320,200 shares $912.57 thousand -5.6%2.1%0.9 $2.85
10/15/2021339,200 shares $1.07 million +8.8%2.2%1 $3.15
9/30/2021311,700 shares $1.04 million -7.6%2.1%1.6 $3.34
9/15/2021337,500 shares $924.75 thousand -2.2%2.2%1.8 $2.74
8/31/2021345,200 shares $963.11 thousand -21.4%2.3%1.2 $2.79
8/13/2021439,000 shares $1.10 million +25.4%2.9%1.6 $2.50
7/30/2021350,200 shares $794.95 thousand -31.4%2.5%1.1 $2.27
7/15/2021510,400 shares $1.22 million +13.8%3.6%1.3 $2.40
6/30/2021448,600 shares $1.20 million +37.1%8.7%1.1 $2.67
6/15/2021327,300 shares $900.08 thousand -15.5%6.4%0.8 $2.75
5/28/2021387,100 shares $917.43 thousand +4.1%5.9%1.4 $2.37
5/14/2021372,000 shares $703.08 thousand +17.2%5.6%1.2 $1.89
4/30/2021317,300 shares $672.68 thousand -0.3%4.8%1 $2.12
4/15/2021318,100 shares $629.84 thousand +40.8%N/A0 $1.98
3/31/2021226,000 shares $474.60 thousand -17.8%1.8%0.6 $2.10
3/15/2021274,800 shares $777.68 thousand +51.3%2.2%0.6 $2.83
2/26/2021181,600 shares $497.58 thousand -6.0%1.5%0.3 $2.74
2/12/2021193,200 shares $662.68 thousand +144.6%1.6%0.3 $3.43
1/29/202179,000 shares $259.12 thousand -64.4%0.9%0.1 $3.28
1/15/2021221,900 shares $561.41 thousand +173.3%2.4%0.3 $2.53
12/31/202081,200 shares $198.94 thousand -60.8%0.9%0.1 $2.45
12/15/2020207,200 shares $426.83 thousand +153.6%2.2%0.3 $2.06
11/30/202081,700 shares $143.79 thousand -15.5%0.9%0.1 $1.76
11/15/202096,700 shares $166.32 thousand -13.8%1.0%0.2 $1.72
10/30/2020112,200 shares $187.37 thousand -74.6%1.3%0.3 $1.67
A new rule goes live in July — and the banks are quietly cashing in (Ad)

A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.

To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how
10/15/2020442,200 shares $902.09 thousand +46.2%N/A1.3 $2.04
9/30/2020302,500 shares $617.10 thousand +6.3%N/A1.7 $2.04
9/15/2020284,700 shares $862.64 thousand +377.7%172.4%1.4 $3.03
8/31/202059,600 shares $157.94 thousand +358.5%36.1%0.3 $2.65
8/14/202013,000 shares $37.83 thousand -54.2%0.1%0.1 $2.91
7/31/202028,400 shares $79.52 thousand -82.7%0.4%0.2 $2.80

ETTX Short Interest - Frequently Asked Questions

What is Entasis Therapeutics' current short interest?

Short interest is the volume of Entasis Therapeutics shares that have been sold short but have not yet been closed out or covered. As of June 15th, investors have sold 72,400 shares of ETTX short. 0.50% of Entasis Therapeutics' shares are currently sold short. Learn More on Entasis Therapeutics' current short interest.

What is a good short interest percentage for Entasis Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.50% of Entasis Therapeutics' floating shares are currently sold short.

Is Entasis Therapeutics' short interest increasing or decreasing?

Entasis Therapeutics saw a decrease in short interest during the month of June. As of June 15th, there was short interest totaling 72,400 shares, a decrease of 3.3% from the previous total of 74,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Entasis Therapeutics' float size?

Entasis Therapeutics currently has issued a total of 47,852,000 shares. Some of Entasis Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Entasis Therapeutics currently has a public float of 14,440,000 shares.

How does Entasis Therapeutics' short interest compare to its competitors?

0.50% of Entasis Therapeutics' shares are currently sold short. Here is how the short interest of companies compare to Entasis Therapeutics: Aerovate Therapeutics, Inc. (21.72%), PyroGenesis Canada Inc. (0.14%), Aadi Bioscience, Inc. (6.58%), Eagle Pharmaceuticals, Inc. (0.46%), Actinium Pharmaceuticals, Inc. (4.54%), NanoViricides, Inc. (1.62%), AEON Biopharma, Inc. (5.67%), China Pharma Holdings, Inc. (2.27%), Orgenesis Inc. (0.13%), Matinas Biopharma Holdings, Inc. (3.13%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.58 billion), Occidental Petroleum Corporation ($3.23 billion), Lucid Group, Inc. ($2.31 billion), Coinbase Global, Inc. ($1.73 billion), Snowflake Inc. ($1.71 billion), Chesapeake Energy Co. ($1.66 billion), Rivian Automotive, Inc. ($1.63 billion), Williams-Sonoma, Inc. ($1.51 billion), Lumen Technologies, Inc. ($1.40 billion), and Diamondback Energy, Inc. ($1.37 billion). View all of the most shorted stocks.

What does it mean to sell short Entasis Therapeutics stock?

Short selling ETTX is an investing strategy that aims to generate trading profit from Entasis Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Entasis Therapeutics?

A short squeeze for Entasis Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ETTX, which in turn drives the price of the stock up even further.

How often is Entasis Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ETTX, twice per month. The most recent reporting period available is June, 15 2022.




This page (NASDAQ:ETTX) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners